WARSAW,
Ind., Sept. 1, 2022 /PRNewswire/ -- Zimmer
Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical
technology leader, today announced an exclusive, multi-year
co-marketing agreement with Surgical Planning Associates, Inc. to
commercialize HipInsight™, the first FDA-cleared mixed
reality navigation system for total hip replacement. HipInsight is
customized for Zimmer Biomet's hip implant portfolio and allows
surgeons to use Microsoft HoloLens 2 glasses to visualize a
hologram of the patient's pelvic anatomy projected on the pelvis
during surgery to support implant placement and alignment.
HipInsight, the latest addition to the OptiVu™ Mixed
Reality portfolio of applications, further expands the capabilities
of the ZBEdge™ suite of integrated smart, digital and
robotic technologies designed to deliver transformative
data-powered insights with the goal of optimizing patient
outcomes.
![(PRNewsfoto/Zimmer Biomet Holdings, Inc.) (PRNewsfoto/Zimmer Biomet Holdings, Inc.)](https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg)
"The addition of HipInsight to our mixed reality portfolio
advances our commitment to transform the surgical experience with
the latest innovative technologies to help surgeons improve
accuracy, strive for better outcomes and optimize efficiency during
total hip arthroplasty," said Nitin
Goyal, MD, Chief Science, Technology and Innovation Officer
at Zimmer Biomet. "This collaboration enables us to offer surgeons
a sophisticated and proven mixed reality-based visualization tool
customized for exclusive use with our hip implant portfolio."
The HipInsight System provides a detailed, Computed Tomography
(CT)-based, 3D surgical plan that includes information important
for accurate and efficient implant positioning, including planned
component size, pelvic tilt, leg length and offset change. During
the surgery, the HipInsight system uses mixed-reality glasses and
the position of a smart registration tool to overlay holograms in
real time on the patient anatomy so that the surgeon can proceed
with the surgical plan in direct view.
"We're proud to partner with Zimmer Biomet, a leader in joint
arthroplasty, to co-market HipInsight for their portfolio of hip
implant systems," said Stephen B.
Murphy, M.D., founder of Surgical Planning Associates.
"Unlike traditional intraoperative surgical navigation systems that
provide information on flat screens outside the surgeon's view,
HipInsight leverages Microsoft HoloLens 2 mixed reality glasses in
a truly innovative fashion to display images and information within
the surgeons' field of view to support accurate implant
positioning. This collaboration is the next step in our journey to
make mixed-reality-based surgical guidance the standard of care in
orthopedics."
For more information about HipInsight™, visit
www.zimmerbiomet.com/optivu.
About OptiVu™ Mixed
Reality
OptiVu Mixed Reality merges real and virtual worlds to provide
innovative solutions enabling surgeons and care teams to educate,
collaborate, and visualize in ways they never have before to create
richer understandings. The platform leverages the Microsoft
HoloLens 2 to deliver a suite of proprietary software applications
using holographic visualizations to support patient education,
streamline surgical planning and workflow, and deliver on demand
and real-time remote support.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a
comprehensive portfolio designed to maximize mobility and improve
health. We seamlessly transform the patient experience through our
innovative products and suite of integrated digital and robotic
technologies that leverage data, data analytics and artificial
intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter
at www.twitter.com/zimmerbiomet.
About Surgical Planning
Associates
Surgical Planning Associates, Inc. (SPA) is an ISO 13485:2016
certified medical technology company that specializes in the
development of innovative, cost-effective preoperative planning and
navigation solutions for use in joint arthroplasty. A pioneer
in the fields of surgical planning and computer-assisted joint
reconstruction, SPA is privately held and based in Boston.
Cautionary Statement Regarding
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements include,
but are not limited to, statements concerning Zimmer Biomet's
expectations, plans, prospects, and product and service offerings,
including new product launches and potential clinical successes.
Such statements are based upon the current beliefs and expectations
of management and are subject to significant risks, uncertainties
and changes in circumstances that could cause actual outcomes and
results to differ materially. For a list and description of some of
such risks and uncertainties, see Zimmer Biomet's periodic reports
filed with the U.S. Securities and Exchange Commission (SEC). These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in Zimmer Biomet's filings with the SEC. Forward-looking statements
speak only as of the date they are made, and Zimmer Biomet
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Readers of this news release are
cautioned not to rely on these forward-looking statements, since
there can be no assurance that these forward-looking statements
will prove to be accurate. This cautionary statement is applicable
to all forward-looking statements contained in this news
release.
Microsoft and HoloLens are trademarks of the Microsoft group of
companies.
ZBH-Corp
Media
|
Investors
|
Meredith Weissman
|
Keri Mattox
|
703-346-3127
|
215-275-2431
|
meredith.weissman@zimmerbiomet.com
|
keri.mattox@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-and-surgical-planning-associates-announce-exclusive-multi-year-co-marketing-agreement-for-hipinsight-mixed-reality-system-for-total-hip-replacement-301615883.html
SOURCE Zimmer Biomet Holdings, Inc.